First Header Logo Second Header Logo

Metabolomic architecture of obesity implicates metabolonic lactone sulfate in cardiometabolic disease.

Das SK, Ainsworth HC, Dimitrov L, Okut H, Comeau ME, Sharma N, Ng MCY, Norris JM, Chen YI, Wagenknecht LE, Bowden DW, Hsu FC, Taylor KD, Langefeld CD, Palmer ND. Metabolomic architecture of obesity implicates metabolonic lactone sulfate in cardiometabolic disease. Mol Metab. 2021 Sep 24; 54:101342.

View in: PubMed